InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
2
T+90 hit rate
33%
T+90 mean return
-5.5%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by BROSHY ERAN, Director. Director active across 2 companies, notably Theravance Biopharma, Inc.. In total, 12 disclosures have been published. Breakdown: 1 buy · 2 sells. Total volume traded: €487k. History available since 26 April 2022. The latest transaction was filed on 14 May 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations12 total
15,757 shares0Common StockSEC:0001256230-26-000002:0
15,757 shares0Common StockSEC:0001256230-26-000002
14,000 shares@ US$20.0050.0% of flowOrdinary SharesSEC:0001256230-25-000009
14,000 shares@ US$20.000.029% mcap50.0% of flowOrdinary SharesSEC:0001256230-25-000009:0
11,928 shares0Common StockSEC:0001415889-25-014182:0
10,649 shares0Ordinary SharesSEC:0001415889-25-014000:0
8,663 shares0Common StockSEC:0001415889-24-014248:0
10,537 shares0Ordinary SharesSEC:0001415889-24-012908:0
193 shares@ US$16.10100.0% of flowCommon StockSEC:0001415889-23-012566:0
Ideal exit: 17 May 2024 (T+270)
9,360 shares0Common StockSEC:0001415889-23-008754:0
9,132 shares0Ordinary SharesSEC:0001415889-23-007374:0
9,852 shares0Ordinary SharesSEC:0001415889-22-004328:0
12 of 12 declarations
About BROSHY ERAN
Eran Broshy is a Board Member at Theravance Biopharma, Inc. and Certara, Inc. He brings a strategic perspective to the board, contributing to the direction and governance of the companies. His diverse experience enriches discussions and decisions within the board.
